These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9207404)

  • 21. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
    Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
    Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paroxysmal nocturnal hemoglobinuria--diagnosis with the help of flow cytometry].
    Vetlesen A; Kjeldsen-Kragh J; Tjonnfjord GE
    Tidsskr Nor Laegeforen; 1999 Oct; 119(26):3909-13. PubMed ID: 10592751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
    Nilsson B; Hagström U; Englund A; Säfwenberg J
    Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.
    Dworacki G; Sikora J; Mizera-Nyczak E; Trybus M; Mozer-Lisewska I; Czyz A; Zeromski J
    Folia Histochem Cytobiol; 2005; 43(2):117-20. PubMed ID: 16044949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
    Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D
    Hematol J; 2001; 2(1):33-7. PubMed ID: 11920231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
    Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
    Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing donor chimerism using flow cytometry in paroxysmal nocturnal haemoglobinuria after stem cell transplantation--a case report.
    Azma RZ; Hamidah NH; Leong CF; Ainoon O; Cheong SK
    Malays J Pathol; 2006 Dec; 28(2):107-12. PubMed ID: 18376800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.
    Asimakopoulos JV; Terpos E; Papageorgiou L; Kampouropoulou O; Christoulas D; Giakoumis A; Samarkos M; Vaiopoulos G; Konstantopoulos K; Angelopoulou MK; Vassilakopoulos TP; Meletis J
    Med Sci Monit; 2014 Jan; 20():123-39. PubMed ID: 24463881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 2. Paroxysmal nocturnal hemoglobinuria].
    Kawaguchi T
    Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1891-7. PubMed ID: 22896991
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expression of CD55 and CD59 in chronic rhinosinusitis and its significance].
    Xia L; Wang Y; Gao W; Gao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 49(12):1021-3. PubMed ID: 25623871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
    Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
    Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Phondeechareon T; Wattanapanitch M; U-Pratya Y; Damkham C; Klincumhom N; Lorthongpanich C; Kheolamai P; Laowtammathron C; Issaragrisil S
    Ann Hematol; 2016 Oct; 95(10):1617-25. PubMed ID: 27465155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
    Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
    Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
    Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
    Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.
    Ferreira VP; Pangburn MK
    Blood; 2007 Sep; 110(6):2190-2. PubMed ID: 17554058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.